Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.27
-1.35 (-4.14%)
At close: Aug 28, 2026, 4:00 PM EDT
30.76
-0.51 (-1.63%)
After-hours: Aug 28, 2026, 7:43 PM EDT
Zenas BioPharma Employees
Zenas BioPharma had 167 employees as of December 31, 2025. The number of employees increased by 37 or 28.46% compared to the previous year.
Employees
167
Change (1Y)
37
Growth (1Y)
28.46%
Revenue / Employee
$5,988
Profits / Employee
-$2,900,503
Market Cap
2.04B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 167 | 37 | 28.46% |
| Dec 31, 2024 | 130 | 23 | 21.50% |
| Sep 30, 2024 | 115 | 31 | 36.90% |
| Jun 30, 2024 | 114 | 30 | 35.71% |
| Mar 31, 2024 | 107 | - | - |
| Sep 30, 2023 | 84 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Agios Pharmaceuticals | 540 |
| Maravai LifeSciences Holdings | 415 |
| Vericel | 398 |
| UroGen Pharma | 300 |
| Zymeworks | 231 |
| Stoke Therapeutics | 170 |
| Nanobiotix | 100 |
ZBIO News
- 12 days ago - Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley - TheFly
- 13 days ago - Zenas BioPharma reports Q2 EPS ($1.77), consensus (75c) - TheFly
- 13 days ago - Zenas BioPharma CFO Jennifer Fox to transition out of role - TheFly
- 14 days ago - Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley - TheFly
- 17 days ago - Zenas BioPharma Slides: Corporate presentation - Filings
- 17 days ago - Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 17 days ago - Zenas BioPharma Earnings release: Q2 2026 - Filings